James Tollitt

7PUBLICATIONS
33CO-AUTHORS
Predictive and prognostic markersPsychology of ageingCardiology (incl. cardiovascular diseases)Neurology and neuromuscular diseasesClinical chemistry (incl. diagnostics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 07, 2026
Safety of Testosterone Therapy in Chronic Kidney Disease: A Propensity Score-Matched Cohort Study.

Lino Merlino, Francesco Rainone, James Tollitt

|Jan 26, 2024
IgA vasculitis nephritis-outcomes in adult-onset disease.

James Stanway, Nina Brown, Afeera Pervez

|Aug 16, 2022
Including measures of chronic kidney disease to improve cardiovascular risk prediction by SCORE2 and SCORE2-OP.

Kunihiro Matsushita, Stephen Kaptoge, Steven H J Hageman

|Jun 04, 2021
Cognitive impairment in patients with moderate to severe chronic kidney disease: the Salford kidney cohort study.

James Tollitt, Aghogho Odudu, Daniela Montaldi

|Dec 08, 2020
Safely reducing haemodialysis frequency during the COVID-19 pandemic.

Michelle Da Silva Lodge, Thilini Abeygunaratne, Helen Alderson

|Nov 28, 2019
Impact of prior stroke on major clinical outcome in chronic kidney disease: the Salford kidney cohort study.

James Tollitt, Aghogho Odudu, Emma Flanagan

Pageof 2